Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) EPS (Basic) (2016 - 2025)

Tandem Diabetes Care's EPS (Basic) history spans 13 years, with the latest figure at -$0.01 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 200.0% year-over-year to -$0.01; the TTM value through Dec 2025 reached -$3.07, down 110.27%, while the annual FY2025 figure was -$3.04, 106.8% down from the prior year.
  • EPS (Basic) reached -$0.01 in Q4 2025 per TNDM's latest filing, up from -$0.31 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.17 in Q4 2021 to a low of -$1.97 in Q1 2025.
  • Average EPS (Basic) over 5 years is -$0.46, with a median of -$0.33 recorded in 2025.
  • Peak YoY movement for EPS (Basic): surged 160.0% in 2021, then tumbled 944.44% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at $0.17 in 2021, then tumbled by 247.06% to -$0.25 in 2022, then crashed by 84.0% to -$0.46 in 2023, then skyrocketed by 102.17% to $0.01 in 2024, then tumbled by 200.0% to -$0.01 in 2025.
  • Per Business Quant, the three most recent readings for TNDM's EPS (Basic) are -$0.01 (Q4 2025), -$0.31 (Q3 2025), and -$0.78 (Q2 2025).